Schaubel Douglas E, Wei Guanghui
Department of Biostatistics, University of Michigan, M4039 SPH II, 1420 Washington Heights, Ann Arbor, MI, 48109-2029, USA.
Biom J. 2007 Aug;49(5):719-30. doi: 10.1002/bimj.200610349.
The Cox proportional hazards model has become the standard in biomedical studies, particularly for settings in which the estimation covariate effects (as opposed to prediction) is the primary objective. In spite of the obvious flexibility of this approach and its wide applicability, the model is not usually chosen for its fit to the data, but by convention and for reasons of convenience. It is quite possible that the covariates add to, rather than multiply the baseline hazard, making an additive hazards model a more suitable choice. Typically, proportionality is assumed, with the potential for additive covariate effects not evaluated or even seriously considered. Contributing to this phenomenon is the fact that many popular software packages (e.g., SAS, S-PLUS/R) have standard procedures to fit the Cox model (e.g., proc phreg, coxph), but as of yet no analogous procedures to fit its additive analog, the Lin and Ying (1994) semiparametric additive hazards model. In this article, we establish the connections between the Lin and Ying (1994) model and both Cox and least squares regression. We demonstrate how SAS's phreg and reg procedures may be used to fit the additive hazards model, after some straightforward data manipulations. We then apply the additive hazards model to examine the relationship between Model for End-stage Liver Disease (MELD) score and mortality among patients wait-listed for liver transplantation.
Cox比例风险模型已成为生物医学研究的标准模型,特别是在以估计协变量效应(与预测相对)为主要目标的研究中。尽管这种方法具有明显的灵活性和广泛的适用性,但选择该模型通常并非因其对数据的拟合度,而是出于惯例和便利性。很有可能协变量是增加而非乘上基线风险,这使得相加风险模型成为更合适的选择。通常假定比例性成立,而未对相加协变量效应的可能性进行评估甚至认真考虑。导致这种现象的一个事实是,许多流行的软件包(如SAS、S-PLUS/R)都有拟合Cox模型的标准程序(如proc phreg、coxph),但截至目前还没有类似的程序来拟合其相加形式的模型,即Lin和Ying(1994)半参数相加风险模型。在本文中,我们建立了Lin和Ying(1994)模型与Cox模型和最小二乘回归之间的联系。我们展示了在经过一些简单的数据处理后,如何使用SAS的phreg和reg程序来拟合相加风险模型。然后,我们应用相加风险模型来研究终末期肝病模型(MELD)评分与等待肝移植患者死亡率之间的关系。